These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 39075555)

  • 1. Cross-talk between circRNAs and m6A modifications in solid tumors.
    Liu F; Gu W; Shao Y
    J Transl Med; 2024 Jul; 22(1):694. PubMed ID: 39075555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
    Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
    Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
    Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
    Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions.
    Wang X; Ma R; Zhang X; Cui L; Ding Y; Shi W; Guo C; Shi Y
    Mol Cancer; 2021 Sep; 20(1):121. PubMed ID: 34560891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Characterization of N6-Methyladenosine CircRNAs and Methyltransferases in the Lens Epithelium Cells From Age-Related Cataract.
    Li P; Yu H; Zhang G; Kang L; Qin B; Cao Y; Luo J; Chen X; Wang Y; Qin M; Wu J; Huang Y; Zou X; Guan H; Wang Y
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):13. PubMed ID: 32761139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of
    Tang M; Lv Y
    Int J Biol Sci; 2021; 17(9):2262-2277. PubMed ID: 34239354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology.
    Wu J; Guo X; Wen Y; Huang S; Yuan X; Tang L; Sun H
    Front Cell Dev Biol; 2021; 9():709299. PubMed ID: 34368159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
    Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
    Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.
    Dou Z; Ma XT; Piao MN; Wang JP; Li JL
    Transl Cancer Res; 2024 Jun; 13(6):3106-3125. PubMed ID: 38988908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
    Liao Y; Han P; Zhang Y; Ni B
    Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects.
    Tang X; Guo M; Zhang Y; Lv J; Gu C; Yang Y
    J Exp Clin Cancer Res; 2024 Aug; 43(1):216. PubMed ID: 39095902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of N
    Zhang L; Hou C; Chen C; Guo Y; Yuan W; Yin D; Liu J; Sun Z
    Mol Cancer; 2020 Jun; 19(1):105. PubMed ID: 32522202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia.
    Fang Z; Ding H; Han J; Fu L; Jin J; Feng W
    J Leukoc Biol; 2024 Oct; 116(4):662-671. PubMed ID: 38721720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Functions of N-methyladenosine (m6A) Modification on HIV-1 mRNA.
    Zhong X; Zhou Z; Yang G
    Cell Biochem Biophys; 2024 Jun; 82(2):561-574. PubMed ID: 38753251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.